<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To report a rare case of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya syndrome</z:e> with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>CLINICAL PRESENTATION AND INTERVENTION: A 41-year-old woman was admitted with sudden <z:hpo ids='HP_0003674'>onset</z:hpo> of left-sided <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Magnetic resonance imaging and magnetic resonance angiography of the brain showed characteristic features of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> vessels </plain></SENT>
<SENT sid="3" pm="."><plain>Laboratory investigations revealed raised levels of anticardiolipin antibody </plain></SENT>
<SENT sid="4" pm="."><plain>She made a complete and uneventful recovery with aspirin and intensive physiotherapy over a period of 2 weeks </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: The association of APS and <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> may present a dilemma in management </plain></SENT>
<SENT sid="6" pm="."><plain>While APS is often considered to be an indication for giving anticoagulation, a trial of antiplatelet agents is preferable to anticoagulation because of the risk of <z:mp ids='MP_0001914'>bleeding</z:mp> from the fragile <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> vessels </plain></SENT>
</text></document>